We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-16.56%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$205B
AUM Growth
-$58.3B
Cap. Flow
-$4.48B
Cap. Flow %
-2.18%
Top 10 Hldgs %
21.11%
Holding
3,330
New
90
Increased
1,600
Reduced
1,393
Closed
130

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.04B
2
UNH icon
UnitedHealth
UNH
+$428M
3
MSFT icon
Microsoft
MSFT
+$410M
4
BAC icon
Bank of America
BAC
+$374M
5
BA icon
Boeing
BA
+$332M

Sector Composition

Rank Sector Weight
1 Technology 22.25%
2 Healthcare 14.77%
3 Financials 12.79%
4 Consumer Discretionary 10.52%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NE
2876
DELISTED
Noble Corporation
NE
$363K ﹤0.01%
1,394,506
+140,814
+11% +$105K
HDB icon
2877
HDFC Bank
HDB
$121B
$362K ﹤0.01%
18,842
-45,734
-71% -$1.23M
RRD
2878
DELISTED
RR Donnelley & Sons Co.
RRD
$361K ﹤0.01%
375,803
+72,706
+24% +$176K
ESXB
2879
DELISTED
Community Bankers Trust Corporation
ESXB
$361K ﹤0.01%
74,540
-404
-0.5% -$3.21K
FPRX
2880
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$361K ﹤0.01%
158,805
+49,117
+45% +$208K
YARW
2881
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$360K ﹤0.01%
37
+29
+363% +$455K
EOLS icon
2882
Evolus
EOLS
$501M
$359K ﹤0.01%
86,483
+20,273
+31% +$172K
STRS icon
2883
Stratus Properties
STRS
$154M
$358K ﹤0.01%
20,216
-1,430
-7% -$39K
BWFG icon
2884
Bankwell Financial Group
BWFG
$533M
$357K ﹤0.01%
23,398
-63
-0.3% -$1.59K
SPRO icon
2885
Spero Therapeutics
SPRO
$73M
$356K ﹤0.01%
44,053
+5,656
+15% +$49.9K
NAGE
2886
Niagen Bioscience
NAGE
$247M
$356K ﹤0.01%
108,999
-96
-0.1% -$369
CONN
2887
DELISTED
Conn's Inc.
CONN
$356K ﹤0.01%
85,247
-367,988
-81% -$3M
LJPC
2888
DELISTED
La Jolla Pharmaceutical Company
LJPC
$356K ﹤0.01%
84,797
+7,619
+10% +$48.1K
FLXS icon
2889
Flexsteel Industries
FLXS
$311M
$353K ﹤0.01%
32,272
-24
-0.1% -$374
CLPR
2890
Clipper Realty
CLPR
$46.2M
$352K ﹤0.01%
67,954
+1,277
+2% +$12.6K
AFI
2891
DELISTED
Armstrong Flooring, Inc.
AFI
$351K ﹤0.01%
245,822
+3,054
+1% +$9.45K
BLE
2892
DELISTED
BlackRock Municipal Income Trust II
BLE
$350K ﹤0.01%
26,189
LCTX icon
2893
Lineage Cell Therapeutics
LCTX
$278M
$350K ﹤0.01%
423,265
-66,546
-14% -$66.3K
GAIA icon
2894
Gaia
GAIA
$48.4M
$346K ﹤0.01%
38,961
+7,380
+23% +$60.1K
CMCT
2895
Creative Media & Community Trust
CMCT
$13M
$344K ﹤0.01%
+1
New +$329K
RMBI icon
2896
Richmond Mutual Bancorp
RMBI
$254M
$344K ﹤0.01%
33,770
+13,144
+64% +$180K
XERS icon
2897
Xeris Biopharma Holdings
XERS
$1.45B
$344K ﹤0.01%
176,294
+53,664
+44% +$231K
ZAGG
2898
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$340K ﹤0.01%
109,222
-320
-0.3% -$2.09K
TWI icon
2899
Titan International
TWI
$475M
$337K ﹤0.01%
216,958
+36,365
+20% +$93.3K
NBN icon
2900
Northeast Bank
NBN
$1.14B
$333K ﹤0.01%
28,518
-1,947
-6% -$35.3K

Similar funds

Nuveen's Q1 2020 Portfolio in Review

As of Q1 2020, Nuveen held 3,330 positions worth $205B, down 22% from $264B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2020 filing shows 90 new, 1,600 increased, 1,393 reduced and 130 closed positions. Its largest new stake was Reynolds Consumer Products: 1,948,067 shares worth $56.8M. The largest sale was Apple, an estimated $1.04B.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q1 2020 buy was Reynolds Consumer Products: 1,948,067 shares worth $56.8M.
  • Nuveen added most to Intel in Q1 2020, an estimated $723M increase.
  • Nuveen's biggest Q1 2020 reduction was Apple, cutting an estimated $1.04B.
  • Nuveen fully exited Liberty Property Trust in Q1 2020, selling an estimated $64M.
  • Nuveen's ten largest holdings make up 21% of its $205B portfolio in Q1 2020.
  • Nuveen opened 90 new positions and closed 130 in Q1 2020.
  • Nuveen's portfolio value fell 22% quarter-over-quarter to $205B.

Based on Nuveen's 13F filing for Q1 2020, filed 14 May 2020.